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valvular heart disease after kidney transplantation 
IntRODuCtIOn: Cardiovascular diseases are the greatest cause of morbidity and mortality in patients after 
kidney transplantation. Valvular heart disease is a common occurrence in patients on chronic dialysis. Abnormali-
ties include valvular and annular thickening and calcification of any of the heart valves, causing regurgitation and/
or stenosis. Valvular thickening or sclerosis in patients on chronic dialysis treatment most commonly affecting 
the aortic and mitral valve. Current knowledge of valvular heart disease in patients after kidney transplantation 
are scarce.
AIM: To determine the prevalence of valvular heart disease in kidney transplant patients and patients treated with 
hemodialysis. To determine whether there is a difference in the prevalence of valvular heart disease among kidney 
transplant patients and patients treated with hemodialysis. 
PAtIents AnD MethODs: We conducted a prospective study that included 90 patients. All patients had 
their history data taken, electrocardiogram, complete physical examination and echocardiography. The diffeence 
in frequency of the observed parameters was tested by chi-sqyare test. 
Results: Patients were divided into two groups: kidney transplant patients (60 patients) and patients treated 
with hemodialysis (30 patients). In the group with kidney transplant patients was 42 (70%) men and 18 (30%) wom-
en. In the group with patients treated with hemodialysis was 15 (50%) men and 15 (50%) women. The average age in 
kidney transplant patients was 42.22 ± 1.71 years, in the group with patients treated with hemodialysis was 52.97 
± 2.98 years. The mean duration of dialisys before kidney transplant in the group with kidney transplant patients 
was 43.00 ± 9.19 months. The average kidney graft survival was 9,1±9,68 years. The mean duration of dialisys in the 
group with patients treated with hemodialysis was 87.00 ± 15.6 months. Tricuspidal regurgitation had 20 (33.33%) 
kidney transplant patients and 12 (40%) patients treated with hemodialysis; p value 0.1988. Mitral regurgation had 
20 (33.33%) kidney transplant patients and 17 (56.67%) patients treated with hemodialysis; p value 0.0294. Aortic 
regurgitation had 9 (15%) kidney transplant patients and 10 (33.33%) patients treated with hemodialysis; p value 
0.0435. Pulmonary valve regurgitation had 0 (0%) kidney transplant patients and 3 (10%) patients treated with he-
modialysis; p value 0.0346. Mitral stenosis had 1 (1.67%) kidney transplant patients and 4 (13.33%) patients treated 
with hemodialysis; p value 0.0407. Aortic stenosis had 1 (1.67%) kidney transplant patients and 2 (6.67%) patients 
treated with hemodialysis; p value 0.2567. 
COnClusIOn: We find statistically significant differences in the frequency of valvular heart disease between 
kidney transplant patients and patients treated with hemodialysis. 
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